FTX – the last word in corporate governance
November 21, 2022
In case any of us forget the importance of good corporate governance, have a look at the administrator John Jay III’s declaration* on the collapse
Author: Simon Laffin
Can we all make better decisions?
March 10, 2022
Making better decisions is the holy grail of the boardroom. Corporate governance is full of rules and procedures, but very little on actual decision-making. There
Share buy-backs in trouble again
March 1, 2022
Lucy Tobin’s article in the Evening Standard drew my eye. Share buy-backs have always seemed to be controversial amongst commentators in the UK, and this
8 Tips to spot dodgy statistics
January 4, 2022
You’ve just seen a report that concludes what you ‘already knew’. Maybe it’s that having more diversity on a board increases profit, or that eating
Interview with PI World
October 25, 2021
A fascinating interview with Simon Laffin on what investors need to know about decisions made in the boardroom. Including, the most common problems facing a
Boards need education not regulation
September 9, 2021
I joined the board of Northern Rock a month after it suffered its humiliating run featuring long queues of anxious savers. This was my first
Is Morrisons property portfolio really worth £9bn?
July 7, 2021
“Fears over Morrisons estate being sold on cheap…The shops, warehouses and factories owned by Wm Morrisons could be worth almost £9 billion – double the
Corporate failures: Education,not more regulation
July 7, 2021
How do we improve corporate performance and avoid more corporate failures? The government is clear: We need more regulation. ‘Restoring trust in audit and corporate
Sir Ken Morrison – his legacy and private equity
July 6, 2021
There is a lot of discussion at the moment about the legacy of Sir Ken Morrison and whether would have approved of a private equity
“A hotchpotch of pet ideas” – White Paper on audit & governance
June 17, 2021
Two successes from the pandemic have been the ‘Recovery’ treatment trials and new vaccines. Medical experts suggested possible options, tested each in blind trials, with